262 related articles for article (PubMed ID: 21075329)
1. Chromosomal aberrations in solid tumors.
Chinnaiyan AM; Palanisamy N
Prog Mol Biol Transl Sci; 2010; 95():55-94. PubMed ID: 21075329
[TBL] [Abstract][Full Text] [Related]
2. The discovery of common recurrent transmembrane protease serine 2 (TMPRSS2)-erythroblastosis virus E26 transforming sequence (ETS) gene fusions in prostate cancer: significance and clinical implications.
Shah RB; Chinnaiyan AM
Adv Anat Pathol; 2009 May; 16(3):145-53. PubMed ID: 19395877
[TBL] [Abstract][Full Text] [Related]
3. [Tumor-type specific translocations methods and indications for routine molecular pathology].
Gattenlöhner S; Müller-Hermelink HK
Verh Dtsch Ges Pathol; 2007; 91():154-9. PubMed ID: 18314609
[TBL] [Abstract][Full Text] [Related]
4. Evidence of recurrent gene fusions in common epithelial tumors.
Kumar-Sinha C; Tomlins SA; Chinnaiyan AM
Trends Mol Med; 2006 Nov; 12(11):529-36. PubMed ID: 17011825
[TBL] [Abstract][Full Text] [Related]
5. The impact of translocations and gene fusions on cancer causation.
Mitelman F; Johansson B; Mertens F
Nat Rev Cancer; 2007 Apr; 7(4):233-45. PubMed ID: 17361217
[TBL] [Abstract][Full Text] [Related]
6. Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer.
Tomlins SA; Laxman B; Dhanasekaran SM; Helgeson BE; Cao X; Morris DS; Menon A; Jing X; Cao Q; Han B; Yu J; Wang L; Montie JE; Rubin MA; Pienta KJ; Roulston D; Shah RB; Varambally S; Mehra R; Chinnaiyan AM
Nature; 2007 Aug; 448(7153):595-9. PubMed ID: 17671502
[TBL] [Abstract][Full Text] [Related]
7. The role of chromosomal alterations in human cancer development.
Gasparini P; Sozzi G; Pierotti MA
J Cell Biochem; 2007 Oct; 102(2):320-31. PubMed ID: 17722107
[TBL] [Abstract][Full Text] [Related]
8. Cancer genome sequencing: the challenges ahead.
Heng HH
Bioessays; 2007 Aug; 29(8):783-94. PubMed ID: 17621658
[TBL] [Abstract][Full Text] [Related]
9. Fusion genes in solid tumors.
Aman P
Semin Cancer Biol; 1999 Aug; 9(4):303-18. PubMed ID: 10448117
[TBL] [Abstract][Full Text] [Related]
10. Prevalence estimates of recurrent balanced cytogenetic aberrations and gene fusions in unselected patients with neoplastic disorders.
Mitelman F; Mertens F; Johansson B
Genes Chromosomes Cancer; 2005 Aug; 43(4):350-66. PubMed ID: 15880352
[TBL] [Abstract][Full Text] [Related]
11. Fusion genes and rearranged genes as a linear function of chromosome aberrations in cancer.
Mitelman F; Johansson B; Mertens F
Nat Genet; 2004 Apr; 36(4):331-4. PubMed ID: 15054488
[TBL] [Abstract][Full Text] [Related]
12. [Significance of chromosomal abnormalities in solid tumors of humans].
Limon J; Mitelman F
Pol J Pathol; 1994; 45(1):1-15. PubMed ID: 8177615
[TBL] [Abstract][Full Text] [Related]
13. [Exploration of novel molecular targets for cancer therapy based on genomic aberrations].
Imoto I; Inazawa J
Gan To Kagaku Ryoho; 2005 Nov; 32(12):1891-4. PubMed ID: 16282722
[TBL] [Abstract][Full Text] [Related]
14. Sequence-based advances in the definition of cancer-associated gene mutations.
Simpson AJ
Curr Opin Oncol; 2009 Jan; 21(1):47-52. PubMed ID: 19125018
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of current molecular cytogenetic protocols for the diagnosis of chromosome aberrations in tumor specimens.
Lichter P; Fischer K; Joos S; Fink T; Baudis M; Potkul RK; Ohl S; Solinas-Toldo S; Weber R; Stilgenbauer S; Bentz M; Döhner H
Cytokines Mol Ther; 1996 Sep; 2(3):163-9. PubMed ID: 9384700
[TBL] [Abstract][Full Text] [Related]
16. From chromosomal alterations to target genes for therapy: integrating cytogenetic and functional genomic views of the breast cancer genome.
Monni O; Hyman E; Mousses S; Barlund M; Kallioniemi A; Kallioniemi OP
Semin Cancer Biol; 2001 Oct; 11(5):395-401. PubMed ID: 11562182
[TBL] [Abstract][Full Text] [Related]
17. Somatic alterations in the human cancer genome.
Weir B; Zhao X; Meyerson M
Cancer Cell; 2004 Nov; 6(5):433-8. PubMed ID: 15542426
[TBL] [Abstract][Full Text] [Related]
18. Non-solid oncogenes in solid tumors: EML4-ALK fusion genes in lung cancer.
Mano H
Cancer Sci; 2008 Dec; 99(12):2349-55. PubMed ID: 19032370
[TBL] [Abstract][Full Text] [Related]
19. [Identification of the breakpoint-flanking markers on chromosomes 1 and 17 of a constitutional translocation T(1;17)(P36;Q12-21) in a patient with neuroblastoma].
Laureys GG
Verh K Acad Geneeskd Belg; 1995; 57(5):389-422. PubMed ID: 8571670
[TBL] [Abstract][Full Text] [Related]
20. [Molecular cytogenetics in diagnostics of malignant diseases].
Michalová K; Zemanová Z
Cas Lek Cesk; 2006; 145(7):532-7. PubMed ID: 16921780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
